TGFB1 and breast carcinoma: Biomimetic nanoparticle delivery systems (e.g., CAF membrane‐coated liposomes) enable precise delivery of TGF‐β siRNA to the TME, achieving synergistic CAF reprogramming and cytokine suppression in breast cancer models.